Long Term Use of Oral Bisphosphonates May Double Risk of Esophageal Cancer
Long Term Use of Oral Bisphosphonates May Double Risk of Esophageal Cancer
From the PharmaLive.com News Archive - Sep. 03, 2010 People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet), according to a new study published on bmj.com today. Oral bisphosphonates are a type of drug used to treat osteoporosis and other bone diseases and are the most commonly recommended treatment for such conditions. http://www.therapeuticsdaily.com/new...e&channelID=26 |
All times are GMT -7. The time now is 02:50 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021